Summary

Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts le than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks.

Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
ICRWorld's Drugs for Sinusitis market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability.
The industry report lists the leading competitors and provides the insights strategic industry analysis of the key factors influencing the market.
The report includes the forecasts, analysis and discuion of important industry trends, market size, market share estimates and profiles of the leading industry players.
The market is expected to expand at 3.36% CAGR over the period between 2019 and 2024.

Global Drugs for Sinusitis Market: Product Segment Analysis
Antibiotics
Corticosteroids
Decongestants
others
Global Drugs for Sinusitis Market: Application Segment Analysis
Acute Sinusitis
Chronic Sinusitis
Global Drugs for Sinusitis Market: Regional Segment Analysis
North America
Europe
China
South East Asia
Japan and India
The players mentioned in our report
Sanofi
Bayer AG
AstraZeneca Plc
Novartis AG.
Johnson & Johnson
Merck
Amgen
Bionorica SE
Dr. Reddy's Laboratories
Pfizer
Huasun